Imaging software developer Arterys has announced its latest round of funding -- a $28 million series C investment from a syndicate led by Benslie Investment Group and Temasek Holdings.
Also participating in the funding are Fosun, Revelation Partners, Emergent Medical Partners, and radiation oncology firm Varian Medical Systems.
The new financing round is intended to help the company expand its ecosystem and accelerate the work of its partners to bring clinical-grade artificial intelligence (AI) applications to healthcare providers and make it easier to integrate AI into their workflow with a single user interface.
In other news, Arterys said it appointed John Axerio-Cilies, PhD, the company's co-founder, as its acting CEO.
